Speaker illustration

Doctor Gentaro Ikeda

Stanford University, Palo Alto (United States of America)

Novel nanoparticle-mediated medicine for myocardial ischemia-reperfusion injury simultaneously targeting mitochondrial injury and myocardial inflammation

Event: Frontiers in CardioVascular Biology 2016

Topic: Oxygen consumption

Session: Oxygen sensing, ischaemia and reperfusion

Thumbnail

This platform is supported by

logo Novo Nordisk